Metabolic Health, Weight Management & GLP-1s
Insights
Market Players

The Weight-Loss Earthquake - GLP-1s Rewrite the Rules of Fitness and Health
Metabolic health’s defining development in 2026 was the widening ecosystem around prescription weight management. Oral medicines, digital support and fitness partnerships created additional ways to serve customers, while making professional boundaries more important rather than less. Eli Lilly announced FDA approval of Foundayo, its oral GLP-1 medicine, in April. Weight Watchers subsequently added access through its Med+ offer for clinically eligible members. The development expanded treatment choice; it did not remove the need for medical assessment, appropriate prescribing or ongoing support. Other announcements addressed the services surrounding medication. Noom launched a free GLP-1 Companion available regardless of the prescribing provider, with medication tracking, nutrition tools, movement resources and habit-building support. That distribution model also raised a commercial question for paid providers: which services remained sufficiently distinctive when basic support became free? Fitness entered the picture through identifiable partnerships. Weight Watchers integrated selected PVOLVE workouts into its programmes, including a dedicated GLP-1 strength series. Everyone Active revealed plans for a Chemists 4U referral relationship, connecting customers considering medication with a pharmacy provider alongside broader fitness support. Together, the developments showed a market being assembled across different roles: pharmaceutical companies, prescribers, digital platforms and exercise businesses. They should not be treated as interchangeable providers of the same service. For clubs, the opportunity is an appropriate programme and a trusted continuing relationship—not a claim to replace medical care. Commercial performance will depend on whether customers find the coaching useful enough to sustain. The year shifted the discussion from whether medication would disrupt fitness towards how fitness could contribute responsibly within a wider weight-management journey.
BIG NEWS STORIES THIS YEAR
- Hims & Hers Adds Wegovy Pill and Injection Access for Eligible Customers
- Lilly Announces FDA Approval of Oral GLP-1 Foundayo
- Noom Launches Free GLP-1 Companion Regardless of Prescribing Provider
- Novo Nordisk Launches Oral Wegovy in the US
- Omada Announces Research on GLP-1 Care, Weight Loss and Body Composition
- Personify Health and 9amHealth Announce Employer Weight-Management Service Transform+
- Solera Adds Noom and GLP-1 Companion to Weight-Management Network
- Weight Watchers Adds Foundayo Access Through Med+
- Weight Watchers Partners With PVOLVE on Dedicated GLP-1 Strength Content
- Withings Announces BodyFit Scale for Segmental Body-Composition Tracking
Dr Glenda Rivoallan
Author, Speaker, Resilience Coach and Lead Author,
Beyond Reps: The Rise of Wellbeing in the Fitness Industry
Jeff G. Zwiefel
Strategic Advisor and Health, Wellness & Performance Executive
Life Time
Dr. Gloria Winters
VP, Health Partnerships & Business Development, and Chief Health Officer,
YMCA of the USA
Emma Barry
Chief of Trouble,
TROUBLE Global
